KIF21B Human Pre-designed siRNA Set A contains three designed siRNAs for KIF21B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF22 Human Pre-designed siRNA Set A contains three designed siRNAs for KIF22 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF23 Human Pre-designed siRNA Set A contains three designed siRNAs for KIF23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF24 Human Pre-designed siRNA Set A contains three designed siRNAs for KIF24 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF26A Human Pre-designed siRNA Set A contains three designed siRNAs for KIF26A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF26B Human Pre-designed siRNA Set A contains three designed siRNAs for KIF26B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF27 Human Pre-designed siRNA Set A contains three designed siRNAs for KIF27 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF2A Human Pre-designed siRNA Set A contains three designed siRNAs for KIF2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF2B Human Pre-designed siRNA Set A contains three designed siRNAs for KIF2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF2C Human Pre-designed siRNA Set A contains three designed siRNAs for KIF2C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF3A Human Pre-designed siRNA Set A contains three designed siRNAs for KIF3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF3B Human Pre-designed siRNA Set A contains three designed siRNAs for KIF3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF3C Human Pre-designed siRNA Set A contains three designed siRNAs for KIF3C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF4A Human Pre-designed siRNA Set A contains three designed siRNAs for KIF4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF5A Human Pre-designed siRNA Set A contains three designed siRNAs for KIF5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF5B Human Pre-designed siRNA Set A contains three designed siRNAs for KIF5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF5C Human Pre-designed siRNA Set A contains three designed siRNAs for KIF5C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF6 Human Pre-designed siRNA Set A contains three designed siRNAs for KIF6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kif6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Kif6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kif6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Kif6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF7 Human Pre-designed siRNA Set A contains three designed siRNAs for KIF7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIF9 Human Pre-designed siRNA Set A contains three designed siRNAs for KIF9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIFAP3 Human Pre-designed siRNA Set A contains three designed siRNAs for KIFAP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIFC1 Human Pre-designed siRNA Set A contains three designed siRNAs for KIFC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIFC2 Human Pre-designed siRNA Set A contains three designed siRNAs for KIFC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIFC3 Human Pre-designed siRNA Set A contains three designed siRNAs for KIFC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Kigamicin C is an anti-tumor antibiotic that selectively kills pancreatic cancer PANC-1 cells only in nutrient-poor conditions. Kigamicin C has antimicrobial activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA)[1].

Kihadanin A (compound 3) is a limonoid NOS3 inhibitor that can be isolated from the methanol extract of Dictamnus dasycarpus root bark. Kihadanin A is useful in the study of hyperuricemia (HUA)[1][2][3].

KIN-8194 is an orally active dual inhibitor of HCK and BTK, with IC50 values of 0.915 and

Kinamycin C is a bacterial metabolite containing a diazo group with anticancer activities. Kinamycin C induces a rapid apoptotic response in K562 cells[1].

KIO-301 chloride hydrochloride is an azobenzene photoswitchable compound that blocks voltage-gated ion channels, including hyperpolarization-activated cyclic nucleotide gating (HCN, during exposure to visible light) ) and voltage-gated potassium channels (voltage-gated potassium channels)[1].

KIO-301 chloride hydrochloride is an azobenzene photoswitchable compound that blocks voltage-gated ion channels, including hyperpolarization-activated cyclic nucleotide gating (HCN, during exposure to visible light) ) and voltage-gated potassium channels (voltage-gated potassium channels)[1].

KIO-301 chloride hydrochloride is an azobenzene photoswitchable compound that blocks voltage-gated ion channels, including hyperpolarization-activated cyclic nucleotide gating (HCN, during exposure to visible light) ) and voltage-gated potassium channels (voltage-gated potassium channels)[1].

KIO-301 chloride hydrochloride is an azobenzene photoswitchable compound that blocks voltage-gated ion channels, including hyperpolarization-activated cyclic nucleotide gating (HCN, during exposure to visible light) ) and voltage-gated potassium channels (voltage-gated potassium channels)[1].

KIO-301 chloride hydrochloride is an azobenzene photoswitchable compound that blocks voltage-gated ion channels, including hyperpolarization-activated cyclic nucleotide gating (HCN, during exposure to visible light) ) and voltage-gated potassium channels (voltage-gated potassium channels)[1].

KIR2DL1 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR2DL2 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR2DL3 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR2DL4 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR2DS1 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

KIR2DS2 Human Pre-designed siRNA Set A contains three designed siRNAs for KIR2DS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.